Charles River Laboratories International Inc (CRL)

Apr 03, 2025

How Is Charles River Laboratories' Stock Performance Compared to Other Health Care Stocks? - MSN

Apr 03, 2025

Apr 03, 2025

Human Microbiome Sequencing Market Key Players Analysis - openPR.com

Apr 03, 2025

Apr 01, 2025

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 01, 2025

Apr 01, 2025

Charles River Integrates Akron Bio’s CSS Line of Liquid Cytokines - Contract Pharma

Apr 01, 2025

Mar 31, 2025

Charles River Labs stock hits 52-week low at $150.19 By Investing.com - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

Charles River & Valo Health's Logica Identifies New Lupus Drug Candidate - MSN

Mar 31, 2025

Mar 31, 2025

Baird Adjusts Charles River Laboratories International Price Target to $155 From $173, Maintains Neutral Rating - MarketScreener

Mar 31, 2025

Mar 31, 2025

Charles River Labs stock hits 52-week low at $150.19 - Investing.com

Mar 31, 2025

Mar 31, 2025

Mawer Investment Management Ltd. Buys 5,769 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Mar 31, 2025

Mar 31, 2025

Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? - MSN

Mar 31, 2025

Mar 27, 2025

Genetic Toxicology Testing Market To Witness Huge Gains Over - openPR

Mar 27, 2025

Mar 27, 2025

Biopharma Layoffs Roundup - Contract Pharma

Mar 27, 2025

Mar 26, 2025

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform - BioSpace

Mar 26, 2025

Mar 25, 2025

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform - Marketscreener.com

Mar 25, 2025

Mar 25, 2025

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica - Business Wire

Mar 25, 2025

Mar 24, 2025

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025

Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025

Mar 21, 2025

Goldman Sachs Downgrades Charles River Laboratories International (CRL) - MSN

Mar 21, 2025

Mar 21, 2025

Demystifying Charles River: Insights From 10 Analyst Reviews - Benzinga

Mar 21, 2025

Mar 21, 2025

Icon stock, Charles River stock downgraded at Goldman (CRL) - Seeking Alpha

Mar 21, 2025

Mar 21, 2025

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga India

Mar 21, 2025

Mar 21, 2025

Goldman Sachs cuts Charles River Labs stock rating, target to $170 - Investing.com India

Mar 21, 2025

Mar 21, 2025

Goldman Sachs cuts Charles River Labs stock rating, target to $170 By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190 - Marketscreener.com

Mar 21, 2025

Mar 20, 2025

Jefferies maintains Charles River Labs stock hold, price target at $169 - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 20, 2025

Mar 20, 2025

Interesting CRL Put And Call Options For November 21st - Nasdaq

Mar 20, 2025

Mar 19, 2025

Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 19, 2025

Mar 18, 2025

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo Finance

Mar 18, 2025

Mar 13, 2025

Earnings call transcript: Charles River Labs beats Q4 2024 forecasts By Investing.com - Investing.com UK

Mar 13, 2025

Mar 13, 2025

Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$171? - Simply Wall St

Mar 13, 2025

Mar 11, 2025

Charles River Laboratories to Present at Barclays Global Healthcare Conference - BioSpace

Mar 11, 2025

Mar 11, 2025

Molecular Breeding Market Insights, Competitive Intelligence and Growth Forecast 2025-2030 - GlobeNewswire Inc.

Mar 11, 2025

Mar 10, 2025

Mutual of America Capital Management LLC Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Mar 10, 2025

Mar 09, 2025

Smartleaf Asset Management LLC Increases Position in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Mar 09, 2025

Mar 08, 2025

Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility - MSN

Mar 08, 2025

Mar 08, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN

Mar 08, 2025

Mar 08, 2025

Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN

Mar 08, 2025

Mar 07, 2025

Charles River announces agreement with Singapore General Hospital - SelectScience

Mar 07, 2025

Mar 06, 2025

Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Citigroup - Defense World

Mar 06, 2025

Mar 06, 2025

Reasons to Retain Charles River Stock in Your Portfolio for Now - Yahoo Finance

Mar 06, 2025

Mar 05, 2025

Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

Mar 05, 2025

Mar 04, 2025

Charles River Laboratories Shares Rise After Citigroup Upgrade -March 04, 2025 at 02:53 pm EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Citi raises Charles River stock rating, lifts target to $175 - Investing.com

Mar 04, 2025